Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
- Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases - CHARLESTOWN, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. SLDB, a life sciences company focused on advancing meaningful …